Details:

Alternative Title:
Open AIDS J
Personal Author:
Sullivan, Patrick S. ; Hanson, Debra L. ; Richardson, James T. ; Brooks, John T. ;
Sullivan, Patrick S. ; Hanson, Debra L. ; Richardson, James T. ; Brooks, John T. ; Less -
Description:
Background: Treating anemia with erythropoietin (EPO) to hemoglobin (Hb) endpoints >11 g/dL may increase risk of serious adverse cardiovascular events. Methods: We used medical records data (1996-2003 from the Adolescent Spectrum of HIV Disease Project [ASD] and 1996-2006 from the HIV Outpatient Study [HOPS]) to describe EPO prescription patterns for mildly, moderately, or severely anemic HIV-infected patients. We calculated proportions prescribed EPO and treated to Hb>12 g/dL, and tested for trends over time. We calculated median hemoglobin at first EPO prescription, and described temporal changes using linear regression. Results: Among 37,395 patients in ASD and 7,005 patients in HOPS, EPO prescription increased over time for moderately anemic patients; for patients with severe anemia, EPO prescription increased only among ASD patients. Hb at EPO prescription decreased over time in ASD patients (median=8.5 g/dL), but not in HOPS patients (median 9.5 g/dL). Percentage of EPO-treated patients with post-treatment Hb>12 g/dL was 18.3% in ASD and stable, and was 56.7% in HOPS and increased over time (p = 0.03). Conclusions: Through 2006, EPO prescription increased over time for patients with moderate or severe anemia. Many patients treated with EPO had post-treatment Hb>12 g/dL. Based on 2011 FDA recommendations, changes in previous prescription practices will be needed.
Subject:
[+]
Anemia
Article
Erythropoietin.
HIV

Source:
Open AIDS J. 2011 ; 5:113-118.;
Document Type:
Journal Article ;
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:28c386ad8583b40b887c198df88ae4602e9e451c37772122b8bfed318c4f2b2c
File Type:

Supporting Files

• 	TOAIDJ-5-113_F4.gif	gif
  	TOAIDJ-5-113_F4.jpg	jpeg
  	license.txt	txt
  	TOAIDJ-5-113.nxml	txt
  	TOAIDJ-5-113_F1.gif	gif
  	TOAIDJ-5-113_F1.jpg	jpeg
  	TOAIDJ-5-113_F2.gif	gif
  	TOAIDJ-5-113_F2.jpg	jpeg
  	TOAIDJ-5-113_F3.gif	gif
  	TOAIDJ-5-113_F3.jpg	jpeg

More +